Patent: 8,088,770
✉ Email this page to a colleague
Summary for Patent: 8,088,770
| Title: | Modulators of pharmacokinetic properties of therapeutics |
| Abstract: | The present application provides for a compound of Formula IV: ##STR00001## or a pharmaceutically acceptable salt, solvate, and/or ester thereof, compositions containing such compounds, therapeutic methods that include the administration of such compounds, and therapeutic methods and include the administration of such compounds with at least one additional therapeutic agent. |
| Inventor(s): | Desai; Manoj C. (Pleasant Hill, CA), Hui; Hon C. (San Mateo, CA), Liu; Hongtao (Cupertino, CA), Sun; Jianyu (San Mateo, CA), Xu; Lianhong (Palo Alto, CA) |
| Assignee: | Gilead Sciences, Inc. (Foster City, CA) |
| Application Number: | 12/217,496 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,088,770
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Grifols Therapeutics Llc | BAYGAM, GAMASTAN S/D | immune globulin (human) | Injection | 101134 | 01/11/1944 | ⤷ Try a Trial | 2027-07-06 |
| Kadmon Pharmaceuticals Llc | INFERGEN | interferon alfacon-1 | Injection | 103663 | 10/06/1997 | ⤷ Try a Trial | 2027-07-06 |
| Grifols Therapeutics Llc | GAMMAKED (KENDRION), GAMUNEX-C | immune globulin injection (human) 10% caprylate/chromatography purified | Injection | 125046 | 08/27/2003 | ⤷ Try a Trial | 2027-07-06 |
| Octapharma Pharmazeutika Produktionsges.m.b.h. | OCTAGAM | immune globulin intravenous (human) | Injection | 125062 | 05/21/2004 | ⤷ Try a Trial | 2027-07-06 |
| Octapharma Pharmazeutika Produktionsges.m.b.h. | OCTAGAM | immune globulin intravenous (human) | Injection | 125062 | 03/26/2007 | ⤷ Try a Trial | 2027-07-06 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
